Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against.

More search options...

Krishna, S (2019) Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against. Malar J, 18 (1). p. 339. ISSN 1475-2875 https://doi.org/10.1186/s12936-019-2976-7
SGUL Authors: Krishna, Sanjeev

Preview

PDF Published Version
Available under License Creative Commons Attribution.
Download (786kB) | Preview

Abstract

Managing multidrug resistant malaria can be problematic if currently available artemisinin-containing anti-malarial combination treatments are not used appropriately. Here, I debate that the best way to manage multidrug resistant malaria is to make best use of existing treatments and to develop new classes of anti-malarial drugs and not to make 'triple combination therapies' when there is already resistance to one or more proposed components.

Item Type:

Article

Additional Information:

© The Author(s) 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Keywords:

1108 Medical Microbiology, Tropical Medicine

SGUL Research Institute / Research Centre:

Academic Structure > Infection and Immunity Research Institute (INII)

Journal or Publication Title:

Malar J

ISSN:

1475-2875

Language:

eng

Dates: